• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Combined Effects of Antenatal Influenza Vaccine and Infant Pneumococcal Conjugate Vaccine: Results from a Randomized, Blinded, Controlled Trial

tetano

Editor, Senior Moderator
J Infect Dis. 2013 Jan 8. [Epub ahead of print]
Combined Effects of Antenatal Influenza Vaccine and Infant Pneumococcal Conjugate Vaccine: Results from a Randomized, Blinded, Controlled Trial.
Omer SB, Zaman K, Roy E, Arifeen SE, Raqib R, Noory L, Seib K, Breiman RF, Steinhoff MC.
Source

Emory University, Rollins School of Public Health, Atlanta, GA 30322, USA.
Abstract

In a 2X2-factorial trial, the efficacy of influenza vaccine (TIV) in pregnancy plus infant pneumococcal conjugate vaccine (PCV7) was higher than TIV or PCV alone. During the influenza circulation period, efficacy of TIV+PCV7 was 72.4% (95%CI: 30.2%-89.1%) against febrile respiratory illness and 66.4% (95%CI: 14.3%-86.9%) against medically-attended acute respiratory illness.

PMID:
23300160
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23300160
 
Back
Top Bottom